Skip to main content
. 2017 Mar 25;2017(3):CD010931. doi: 10.1002/14651858.CD010931.pub2

Comparison 33. Exposure to any drug; comparison group: subfertile; any; follow‐up >10 years.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Endometrial cancer; subgroup by effect estimate 4 39671 Risk Ratio (Random, 95% CI) 0.95 [0.63, 1.44]
1.1 RR 2 12548 Risk Ratio (Random, 95% CI) 1.31 [0.61, 2.81]
1.2 IRR 1 2431 Risk Ratio (Random, 95% CI) 1.0 [0.49, 2.06]
1.3 HR 1 24692 Risk Ratio (Random, 95% CI) 0.71 [0.36, 1.39]